Eli Lilly and Company v. Rio Biopharmaceuticals, Inc. - 1:26-cv-00986

Eli Lilly and Company v. Rio Biopharmaceuticals, Inc. (Case No. 1:26-cv-00986), filed on Aug 6, 2026 in the District Court, D. Delaware involving patent infringement. This case involves patent infringement claims between the parties. Explore details about the litigants, key filings, and major docket updates.

Case Details

Case Number
1:26-cv-00986
Filing Date
Aug 6, 2026
Cause of Action
Patent Infringement
Status
-
Court
District Court, D. Delaware
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Eli Lilly and Company -
Rio Biopharmaceuticals, Inc. -

Patents Involved

This case involves 10 patents, each of which is central to the dispute. These patents may be subject to claims of infringement, challenges to their validity, or other issues concerning their scope and enforcement.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Aug 7, 2026Summons Issued as to EMS S/A on 8/7/2026; Rio Biopharmaceuticals, Inc. on 8/7/2026. (Attachments: # 1 Summons Issued)(oam) (Entered: 08/07/2026)PACER Document
Aug 6, 2026Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Eli Lilly and Company. (oam) (Entered: 08/07/2026)PACER Document
Aug 6, 2026Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,474,780 B2; 11,357,820 B2; 11,918,623 B2; 12,295,987 B2 ; 12,343,382 B2.; 12,453,755 B2; 12,453,756 B2; 12,453,758 B2; 12,616,740 B2; 12,629,404 B2. (Entered: 08/07/2026)PACER Document
Aug 6, 2026Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 07/09/2026. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 11/13/2029. (oam) Modified on 8/7/2026 (nms). (Entered: 08/07/2026)PACER Document
Aug 6, 2026Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (oam) (Entered: 08/07/2026)PACER Document
Aug 6, 2026COMPLAINT against EMS S/A and Rio Biopharmaceuticals, Inc. (Filing fee $ 405, receipt number ADEDC-5035428) - filed by Eli Lilly and Company. (Attachments: # 1 Exhibits A-J, # 2 Civil Cover Sheet)(oam) (Entered: 08/07/2026)PACER Document
Aug 7, 2026NOTICE of Appearance by Cortlan S. Hitch on behalf of EMS S/A, Rio Biopharmaceuticals, Inc. (Hitch, Cortlan) (Entered: 08/07/2026)PACER Document
Aug 7, 2026NOTICE of Appearance by Kenneth Laurence Dorsney on behalf of EMS S/A, Rio Biopharmaceuticals, Inc. (Dorsney, Kenneth) (Entered: 08/07/2026)PACER Document
Aug 7, 2026CORRECTING ENTRY: Patent Numbers added to D.I. 4 . (oam)PACER Document
Aug 6, 2026COMPLAINT against EMS S/A and Rio Biopharmaceuticals, Inc. (Filing fee $ 405, receipt number ADEDC-5035428) - filed by Eli Lilly and Company. (Attachments: # 1 Exhibits A-J, # 2 Civil Cover Sheet)(oam) (Entered: 08/07/2026)Attachment
Aug 6, 2026COMPLAINT against EMS S/A and Rio Biopharmaceuticals, Inc. (Filing fee $ 405, receipt number ADEDC-5035428) - filed by Eli Lilly and Company. (Attachments: # 1 Exhibits A-J, # 2 Civil Cover Sheet)(oam) (Entered: 08/07/2026)Attachment